<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1906">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04389489</url>
  </required_header>
  <id_info>
    <org_study_id>MTalmacCarol</org_study_id>
    <nct_id>NCT04389489</nct_id>
  </id_info>
  <brief_title>Postpartum Sexual Function in Pregnant Women With COVID-19</brief_title>
  <official_title>Evaluation of Pregnant Women Diagnosed With COVID-19 Using Carol Postpartum Sexual Function and Dyspareunia Scale</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kanuni Sultan Suleyman Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kanuni Sultan Suleyman Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to identify women with postpartum sexual dysfunction and dyspareunia
      risk in the early period and to use the treatment and care services they need effectively.
      Our secondary aim is to reveal the difference in sexual life in the postpartum period between
      healthy pregnant women and pregnant women diagnosed with COVID-19.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 14, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 25, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of pregnant women diagnosed with COVID-19 using Carol Postpartum Sexual Function and Dyspareunia Scale</measure>
    <time_frame>3 months</time_frame>
    <description>In the study planned to be carried out, it is aimed to identify women at risk of postpartum sexual dysfunction and dyspareunia early and benefit from the treatment and care services they need effectively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of pregnant women diagnosed with COVID-19 using Carol Postpartum Sexual Function and Dyspareunia Scale</measure>
    <time_frame>3 Months</time_frame>
    <description>To reveal the difference in sexual life in postpartum period between healthy pregnant women and pregnant women diagnosed with COVID-19.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">140</enrollment>
  <condition>COVID-19</condition>
  <condition>Dyspareunia</condition>
  <condition>Postpartum Period</condition>
  <eligibility>
    <study_pop>
      <textblock>
        In the reproductive age between 18-45 years old, two groups of 70 people will be selected,
        consisting of puerperant diagnosed with COVID-19 and healthy puerperant. Patients who have
        cesarean or vaginal delivery at the end of the study group, who do not have sexual
        intercourse dysfunction for another reason (such as Stage 3-4 perineal injury, vaginismus)
        will be selected.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant Patient with COVID-19

        Exclusion Criteria:

          -  Those with known sexual dysfunction disorder
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Merve Aldikactioglu Talmac, M.D.</last_name>
    <phone>+905325602366</phone>
    <email>drmrve@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kanuni Sultan Suleyman Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <state>Halkali</state>
        <zip>34307</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Merve Aldikactioglu Talmac, M.D.</last_name>
      <phone>+905325602366</phone>
      <email>drmrve@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>López-Lapeyrere C, Serna-Gómez N, Hernández-López AB, Pérez-García MF, Tejeda-Esteban A, Solís-Muñoz M. The development and validation of a new postpartum sexual function and dyspareunia assessment tool: The Carol Scale. Midwifery. 2018 Mar;58:27-36. doi: 10.1016/j.midw.2017.11.008. Epub 2017 Dec 6.</citation>
    <PMID>29277039</PMID>
  </reference>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>May 14, 2020</study_first_submitted>
  <study_first_submitted_qc>May 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 15, 2020</study_first_posted>
  <last_update_submitted>August 31, 2020</last_update_submitted>
  <last_update_submitted_qc>August 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kanuni Sultan Suleyman Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Merve Aldikactioglu Talmac, MD</investigator_full_name>
    <investigator_title>Specialist of Obstetrics and Gynecology</investigator_title>
  </responsible_party>
  <keyword>Postpartum Period</keyword>
  <keyword>Dyspareunia</keyword>
  <keyword>COVID-19</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyspareunia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

